EUVIMEDEUVIMED entdecken
Crossref

Study of possible relation between maternal serum resistin and insulin resistance in patients with preeclampsia

AlyaaA El-Sherbeny, Manal Mohsen, EmanA Algohary, SaefyaH Hassan, EmadA Abd El-Hadi, Abdel LatifG El-Kholy

Egyptian Journal of Obesity, Diabetes and Endocrinology · 2015

DOI: 10.4103/2356-8062.170205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Egyptian Journal of Obesity, Diabetes and Endocrinology, 2015. Verfasst von AlyaaA El-Sherbeny und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In humans, resistin antagonizes the effects of insulin on glucose metabolism in the liver and skeletal muscle, interacts with and reinforces inflammatory pathways, and may promote endothelial cell activation. Increased resistin levels have been associated with obesity, insulin resistance, metabolic syndrome, type 2 diabetes, and increased cardiovascular risk.

Objectives

Our study aimed to investigate the utility of maternal serum resistin in women with preeclampsia compared with normal pregnant women and its relation to insulin resistance. Patients and methods This study was carried out on 90 women who were divided into two groups: group I: preeclampsia ( n = 60) and group II: healthy pregnant controls ( n = 30). All individuals were subjected to the following after an informed oral and written consent was obtained: full assessment of history, clinical examination with a special focus on edema, blood pressure measurement, and maternal BMI [weight (kg)/height 2 (m 2 )]. Gestational age was determined according to the date of the last menstrual period and confirmed by first-trimester ultrasound. Laboratory investigations including complete blood count, aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, creatinine, homeostasis model assessment-insulin resistance (HOMA-IR), and serum resistin were performed.

Results

Statistical comparison between preeclamptic patients (group I) and the healthy control group (group II) in terms of the different parameters studied showed a highly statistically significant increase in the patient group compared with the control group in systolic blood pressure, diastolic blood pressure, BMI, creatinine (CRE), aspartate aminotransferase, alanine aminotransferase, 50 g oral glucose challenge test, fasting blood glucose, fasting insulin, HOMA-IR, and resistin. In contrast, there was a highly statistically significant decrease in the patient group than the control group in haemoglobin (HB).

Conclusion

In this study, it was found that elevated serum resistin levels could be associated with exaggerated insulin resistance in patients with preeclampsia. Further studies are needed to clarify the role of resistin in the pathophysiology of preeclampsia and insulin resistance.

Zitieren

APA

El-Sherbeny, A., Mohsen, M., Algohary, E., Hassan, S., El-Hadi, E. A., & El-Kholy, A. L. (2015). Study of possible relation between maternal serum resistin and insulin resistance in patients with preeclampsia. Egyptian Journal of Obesity, Diabetes and Endocrinology. https://doi.org/10.4103/2356-8062.170205

Vancouver

El-Sherbeny A, Mohsen M, Algohary E, Hassan S, El-Hadi EA, El-Kholy AL. Study of possible relation between maternal serum resistin and insulin resistance in patients with preeclampsia. Egyptian Journal of Obesity, Diabetes and Endocrinology. 2015. doi:10.4103/2356-8062.170205

BibTeX
@article{ElSherbeny2015,
  author = {El-Sherbeny, AlyaaA and Mohsen, Manal and Algohary, EmanA and Hassan, SaefyaH and El-Hadi, EmadA Abd and El-Kholy, Abdel LatifG},
  title = {Study of possible relation between maternal serum resistin and insulin resistance in patients with preeclampsia},
  journal = {Egyptian Journal of Obesity, Diabetes and Endocrinology},
  year = {2015},
  doi = {10.4103/2356-8062.170205}
}
Kostenlos starten →